We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Motorola Solutions
MSI
$77.4B
| $13.3M | 0.03% |
64,295
-271,830
| -81% | -$59.3M |
|
|
EFOR
602
Everforth Inc
EFOR
$1.33B
| $13.3M | 0.03% |
152,611
+31,345
| +26% | +$3.21M |
|
603
Carter's
CRI
$1.47B
| $13.3M | 0.03% |
192,366
-15,308
| -7% | -$1.23M |
|
604
US Foods
USFD
$24.2B
| $13.3M | 0.03% |
441,025
+244,172
| +124% | +$8.26M |
|
|
LSXMK
605
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $13.2M | 0.03% |
478,356
+288,787
| +152% | +$9.11M |
|
|
HES
606
DELISTED
Hess
HES
| $13.2M | 0.03% |
124,788
+24,082
| +24% | +$2.72M |
|
|
PDCO
607
DELISTED
Patterson Companies, Inc.
PDCO
| $13.2M | 0.03% |
436,291
-167,997
| -28% | -$5.26M |
|
608
Aramark
ARMK
$15.8B
| $13M | 0.03% |
602,913
+33,181
| +6% | +$820K |
|
609
Power Integrations
POWI
$3.61B
| $12.9M | 0.03% |
173,678
+1,672
| +1% | +$136K |
|
610
Erie Indemnity
ERIE
$13.2B
| $12.8M | 0.03% |
68,721
+4,152
| +6% | +$722K |
|
611
Charter Communications
CHTR
$18.2B
| $12.8M | 0.03% |
27,708
+1,313
| +5% | +$640K |
|
612
OGE Energy
OGE
$9.56B
| $12.7M | 0.03% |
331,753
-7,006
| -2% | -$278K |
|
613
New York Times
NYT
$10.4B
| $12.7M | 0.03% |
455,459
+176,843
| +63% | +$6.39M |
|
|
NSA
614
DELISTED
National Storage Affiliates Trust
NSA
| $12.7M | 0.03% |
253,619
+71,188
| +39% | +$3.88M |
|
615
Healthpeak Properties
DOC
$14.3B
| $12.6M | 0.03% |
491,549
+450,369
| +1,094% | +$13.6M |
|
|
ONC
616
BeOne Medicines Ltd
ONC
$41.1B
| $12.6M | 0.03% |
77,611
-341
| -0.4% | -$53.3K |
|
617
Envista
NVST
$4.58B
| $12.3M | 0.03% |
324,676
+51,714
| +19% | +$2.17M |
|
618
Ryder
R
$10.1B
| $12.3M | 0.03% |
177,324
-550,449
| -76% | -$40.4M |
|
|
IAA
619
DELISTED
IAA, Inc. Common Stock
IAA
| $12.2M | 0.03% |
379,801
-85,795
| -18% | -$3.14M |
|
620
Northrop Grumman
NOC
$81.7B
| $12.2M | 0.03% |
26,312
-27,950
| -52% | -$12.8M |
|
621
Extra Space Storage
EXR
$31.1B
| $12.1M | 0.03% |
71,256
+8,994
| +14% | +$1.67M |
|
622
Yeti Holdings
YETI
$3.93B
| $12.1M | 0.03% |
280,276
+206,372
| +279% | +$10M |
|
623
Jacobs Solutions
J
$17.2B
| $12.1M | 0.03% |
118,421
-60,316
| -34% | -$6.75M |
|
|
SKX
624
DELISTED
Skechers
SKX
| $12.1M | 0.03% |
344,359
-13,921
| -4% | -$534K |
|
625
Corpay
CPAY
$26.7B
| $12M | 0.03% |
58,812
-26,012
| -31% | -$6.2M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.